Compare SIRI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SIRI | RGEN |
|---|---|---|
| Founded | 2013 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 8.2B |
| IPO Year | 1994 | N/A |
| Metric | SIRI | RGEN |
|---|---|---|
| Price | $22.08 | $165.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 10 |
| Target Price | $25.22 | ★ $170.90 |
| AVG Volume (30 Days) | ★ 3.5M | 826.7K |
| Earning Date | 10-30-2025 | 10-28-2025 |
| Dividend Yield | ★ 4.90% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.83 | 0.03 |
| Revenue | ★ $8,553,000,000.00 | $707,890,000.00 |
| Revenue This Year | $0.07 | $17.84 |
| Revenue Next Year | $0.01 | $12.57 |
| P/E Ratio | ★ $7.79 | $5,343.41 |
| Revenue Growth | N/A | ★ 11.74 |
| 52 Week Low | $18.69 | $102.97 |
| 52 Week High | $29.18 | $182.52 |
| Indicator | SIRI | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 58.41 | 58.40 |
| Support Level | $20.51 | $161.67 |
| Resistance Level | $21.28 | $170.40 |
| Average True Range (ATR) | 0.60 | 5.85 |
| MACD | 0.14 | 0.09 |
| Stochastic Oscillator | 90.32 | 67.15 |
Sirius XM operates almost exclusively in the US through its SiriusXM and Pandora audio services. SiriusXM is primarily a satellite radio service that offers nationwide coverage and mostly ad-free listening, with proprietary channels and exclusive content. It makes agreements with automakers to install its radios in vehicles and give trial services to vehicle buyers, which have traditionally fed its subscriber base. The company provides the service through a handful of geostationary satellites that it owns and operates; it now offers a streaming SiriusXM option as well. Pandora, which makes up a much smaller portion of revenue and profit, offers a subscription and ad-supported streaming music service that competes with industry giants like Spotify, Apple Music, and YouTube Music.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.